Feb 23 2005
A new company formed by merchant bankers Viscogliosi Bros. LLC (VB) to create a single source of small bone & joint implant products will debut at this month's American Academy of Orthopaedic Surgeons annual convention (Feb.23-27).
During the past year, VB has quietly acquired US and European companies and technologies in the 'small bone' field, as well as licensing and distribution rights for a unique Swedish biological treatment for arthritic thumbs and 'Actipore' porous metal technology from Biorthex, Inc., Montreal, Canada. The group has been formed by VB under the new entity, Small Bone Innovations, LLC (SBI), headquartered in New York.
VB is regarded as a pioneering force in the discovery and development of promising orthopaedic technologies. In 2003, the firm sold its artificial spine disc company, Spine Solutions, Inc., to Synthes, Inc., of Switzerland, for $350 million. The firm has been credited with creating the concept of spine arthroplasty as an alternative to fusion in repairing spinal disc diseases.
Anthony G. Viscogliosi, Chairman and CEO of SBI and a principal of VB, said: "We recognized the potential for growth and innovation in small bone surgery a decade ago. With the prevalence of arthritis in our aging population, surgical techniques are a compelling alternative to drug therapy. As a result, we have translated that vision into a company quite different from competitors in the sector by becoming a vertically integrated, single source of products and technology for small bone & joint surgeons." SBI has more than 50 employees in the US and Europe and has assembled a broad portfolio of FDA-approved implants to treat both small bone & joint degenerative diseases and trauma patients.
http://www.vbllc.com/